دورية أكاديمية
Role of Bisoprolol in Heart Failure Management: A Consensus Statement from India.
| العنوان: | Role of Bisoprolol in Heart Failure Management: A Consensus Statement from India. |
|---|---|
| المؤلفون: | Chopra HK; Senior Consultant, Department of Cardiology, Medanta Moolchand Heart Center, Delhi, India., Nair T; Head, Department of Cardiology, PRS Hospital, Trivandrum, Kerala, India., Wander GS; Professor, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India, Corresponding Author., Ponde CK; Consultant Cardiologist and Head, Department of Cardiology, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India., Ray S; Director, Department of Invasive Cardiology, AMRI Hospital, Kolkata, West Bengal, India., Khullar D; Chairman, Nephrology and Renal transplant Medicine, Dept. of Nephrology and Renal transplant medicine, Max Super-speciality Hospital, Delhi, India., Nanda NC; Distinguished Professor of Medicine and Cardiovascular Disease, Division of Cardiology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Kasliwal RR; Chairman, Department of Clinical and Preventive Cardiology, Medanta-The Medicity, Gurgaon, Haryana, India., Rana DS; Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi, India., Kirpalani A; Consultant Nephrologist, Bombay Hospital, Mumbai, Maharashtra, India., Sawhney JPS; Chief of Clinical and Preventive Cardiology, Chairman, Department of Cardiology, Sir Gangaram Hospital, Delhi, India., Chandra P; Chairman, Department of Interventional and Structural Heart Cardiology, Medanta - The Medicity, Gurgaon, Haryana, India., Mehta Y; Director, Dept of Critical care medicine, Medanta Institute of Critical care Anaesthesiology, Medanta, The Medicity, Gurgaon, Haryana, India., Kumar V; Principal Director and Chief of Cath Labs (Pan Max), Department of Cardiac Sciences, Max Hospital, Delhi, India., Tewari S; Professor of Cardiology at SGPGIMS, Lucknow, Uttar Pradesh, India., Pancholia AK; Head of Department, Department of Clinical and Preventive Cardiology, Arihant Hospital and Research Centre, Indore, Madhya Pradesh, India., Kher V; Chairman, Department of Nephrology, Department of Kidney Transplant, Epitome Kidney Urology Institute and Lions Hospital, Delhi, India., Bansal S; Consultant in Cardiology, Professor and Head, Department of Cardiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, Delhi, India., Mittal S; Senior Cardiologist, Medanta-The Medicity ,Gurgaon, Haryana, India., Kerkar P; Senior Consultant Interventional Cardiologist, Asian Heart Institute, Mumbai, Maharashtra, India., Sahoo PK; Interventional Cardiology, Department of Cardiology, Apollo Hospital, Bhubaneshwar, Odisha, India., Hotchandani R; Consultant, Head, Department of Nephrology, Moolchand Centre for Renal Care and Dialysis, Moolchand Hospital, Delhi, India., Prakash S; Senior Director and Head, Department of Nephrology and Renal Transplantation, BLK-Max Super Speciality Hospital, Delhi, India., Chauhan N; Senior Cardiologist, Medanta-The Medicity ,Gurgaon, Haryana, India., Rastogi V; Director, Department of Interventional Cardiology, Head of Advanced Heart Failure Program, Fortis Escort Heart Institute, Delhi, India., Jabir A; Senior Cardiologist and Assistant Professor, Lisie Hospital, Cochin, Kerala, India., Shanmugasundaram S; Senior Cardiologist, Billroth Hospitals, Chennai, Tamil Nadu, India., Tiwaskar M; Consultant Physician and Diabetologist, Shilpa Medical Research Centre, Mumbai, Maharashtra, India., Sinha A; Senior Consultant, Department of Cardiology, Medanta Heart Institute, Patna, Bihar, India., Gupta V; Consulting Physician, Department of Internal Medicine, Kishori Ram Hospital and Diabetes Care Centre, Bhatinda, Punjab, India., Mishra SS; Director and Senior Consultant Cardiologist, Med N Heart Clinic, Cuttack, Odisha, India., Routray SN; Professor and Head, Department of Cardiology, SCB Medical College, Cuttack, Odisha, India., Omar AK; Director, Fortis Escorts Heart Institute, Department of Non-invasive Cardiology, Delhi, India., Swami OC; Sr. Vice President, Medical Services, Alembic Pharmaceuticals Ltd, Mumbai, Maharashtra, India., Jaswal A; Director, Department of Cardiac Pacing and Electrophysiology, Fortis Escorts Heart Institute, Delhi, India., Alam S; Consultant Interventional Cardiologist, Jayprabha Medanta Super Speciality Hospital, Patna, Bihar, India., Passey R; Consultant Cardiologist, Sir Ganga Ram Hospital, Delhi, India., Rajput R; Senior Consultant Cardiologist, Apollo Hospitals, Delhi, India., Paul J; Professor of Cardiology, Madras Medical College, Chennai, Tamil Nadu, India., Kapoor A; Head, Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India., Prabhakar D; Consultant Interventional Cardiologist, Ashwin Clinic, Chennai, Tamil Nadu, India., Chandra S; Chairman and Head, Dept. of Cardiology and Structural Heart Disease, BLK Max Superspeciality Hospital, Delhi, India., Malhotra P; Senior Professor, Cardiac Anaesthesia, All India Institute of Medical Sciences, Delhi, India., Singh VP; Sr. Consultant, Interventional Cardiologist, Fortis Escort Heart Institute, Delhi, India., Bansal M; Senior Cardiologist, Medanta-The Medicity ,Gurgaon, Haryana, India., Shah P; Assistant General Manager, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India., Jain S; Associate Vice President, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India., Bhargava M; Director of Cardiology and Interventional Cardiologist, Max Hospital, Delhi, India., Vijayalakshmi IB; Professor Emeritus, Former Head Pediatric Cardiology, Shri Jayadeva Institute of Cardiovascular sciences and Research, Bengaluru, Karnataka, India., Varghaese K; Professor and Former Head, Department of Cardiology, St. John's Medical College, Bangalore, India., Jain D; Professor and Former head, Department of Cardiology, IMS, BHU, Varanasi, Uttar Pradesh, India., Goel A; Director, Interventional Cardiology, Max Super-speciality hospital, Delhi, India., Gaur N; CVTS, AIIMS Rishikesh, Rishikesh, Uttarakhand, India., Tandon R; Consultant, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India., Moorthy A; Senior Consultant Cardiologist, SIMS Hospital, Chennai, Tamil Nadu, India., George S; Sree Mookambika Institute of Medical Sciences, Thiruvananthapuram, Kerala, India., Katyal VK; Head of Dept. Department of General Medicine, Positron Hospital; Formerly Senior Professor, Department of Medicine, Pt. B.D.Sharma, Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India., Mantri RR; Director, Department of Cardiology, Sir Ganga Ram Hospital, Delhi, India., Mehrotra R; Director and Head, Department of Non-Invasive Cardiology, Max Super Speciality Hospital, Delhi, India., Bhalla D; Senior Director, Department of Nephrology and Renal Transplant, Max Super Speciality Hospital, Delhi, India., Mittal V; Senior Consultant Diabetologist and Head, Centre for Diabetes and Metabolic Diseases, Heart and Lung Institute, Delhi, India., Rao S; Sr. Interventional Cardiologist, Director Cath Lab, Apollo Hospital, Indore, Madhya Pradesh, India., Jagia M; Director, Department of Anaesthesia and Critical care, Moolchand Hospital, Delhi, India., Singh H; Consultant, Critical Care Specialist, Max Super-speciality hospital, Ghaziabad, Uttar Pradesh, India., Awasthi S; Consultant, Critical Care Specialist, Moolchand Hospital, Delhi, India., Sattur A; Director of Cath Lab HCG, Suchiraya Hospital, Hubli, Karnataka, India., Mishra R; Consultant Cardiologist, Indraprastha, Apollo Hospital, Delhi, India., Pandey A; Sr. Consultant Cardiologist, Delhi, India., Chawla R; Sr. Consultant Diabetologist and Director of North Delhi Diabetes and Cardiac Centre, Delhi, India., Jaggi S; Consultant Diabetologist and Head at Dr. Mohans Diabetes Specialities Centre, Delhi, India., Sehgal B; Sr. Consultant Nephrology, Shree Balaji Action Medical Institute, Delhi, India., Sehgal A; Head of Dept. and Chief Interventional Cardiologist, Yeshoda Superspeciality Hospital, Ghaziabad, Uttar Pradesh, India., Goel N; Sr. cardiologist, Department of Cardiology BLK Super-speciality Hospital, Delhi, India., Gupta R; Interventional Cardiologist, Max Super Speciality hospital, Delhi, India., Kubba S; Director and Unit Head, Cardiology Department Dharmshila Narayana Superspeciality Hospital, Delhi, India., Chhabra A; Interventional Cardiologist, Fortis Hospital, Delhi, India., Bagga S; Senior Cardiologist, Medanta-The Medicity ,Gurgaon, Haryana, India., Shastry NR; Consultant Cardiologist, Medanta Moolchand Heart Center, Delhi, India. |
| المصدر: | The Journal of the Association of Physicians of India [J Assoc Physicians India] 2023 Dec; Vol. 71 (12), pp. 77-88. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Association of Physicians of India Country of Publication: India NLM ID: 7505585 Publication Model: Print Cited Medium: Print ISSN: 0004-5772 (Print) Linking ISSN: 00045772 NLM ISO Abbreviation: J Assoc Physicians India Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Bombay : Association of Physicians of India Original Publication: Bombay [1953?]- |
| مواضيع طبية MeSH: | Bisoprolol*/therapeutic use , Heart Failure*/drug therapy , Adrenergic beta-1 Receptor Antagonists*/therapeutic use, Humans ; India ; Consensus |
| مستخلص: | In India, heart failure (HF) is an important health concern affecting younger age groups than the western population. A limited number of Indian patients receive guideline-directed medical therapy (GDMT). Selective β-1 blockers (BB) are one of the GDMTs in HF and play an important role by decreasing the sympathetic overdrive. The BB reduces heart rate (HR) reverse the adverse cardiac (both ventricular and atrial), vascular, and renovascular remodeling seen in HF. Bisoprolol, a β-1 blocker, has several advantages and can be used across a wide spectrum of HF presentations and in patients with HF and comorbid conditions such as coronary artery disease (CAD), atrial fibrillation (AF), post-myocardial infarction (MI), uncontrolled diabetes, uncontrolled hypertension, and renal impairment. Despite its advantages, bisoprolol is not optimally utilized for managing HF in India. This consensus builds on updated evidence on the efficacy and safety of bisoprolol in HF and recommends its place in therapy with a focus on Indian patients with HF. (© Journal of the Association of Physicians of India 2023.) |
| المشرفين على المادة: | Y41JS2NL6U (Bisoprolol) 0 (Adrenergic beta-1 Receptor Antagonists) |
| تواريخ الأحداث: | Date Created: 20240513 Date Completed: 20240513 Latest Revision: 20240513 |
| رمز التحديث: | 20240513 |
| DOI: | 10.59556/japi.71.0426 |
| PMID: | 38736057 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0004-5772 |
|---|---|
| DOI: | 10.59556/japi.71.0426 |